TRAT1 and non-small cell lung carcinoma: Decreased expression levels of TRAT1 are associated with poor prognosis in patients with NSCLC, LAC, and LUSC and are associated with smoking, clinical stage, histological subtype, and lymph node metastasis in patients with LAC.